Advertisement
argenx SE

argenx SE (ARGNF) Stock Overview

Explore argenx SE’s financial performance, market position, analyst ratings, and future outlook.

ARGNFPNK
HealthcareBiotechnology
$885.00
$0.00(0.00%)
U.S. Market opens in 7h 23m
Advertisement

argenx SE (ARGNF)

Meyka AI Score

Z

Key Financials

Market Cap54.8B
P/E Ratio37.03
EPS (TTM)$22.48
ROE0.23%
Fundamental Analysis

AI Price Forecasts

1 Month$841.14
3 Months$778.81
1 Year Target$887.72

ARGNF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of argenx SE (ARGNF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 79.86, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $887.72.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 37.03 and a market capitalization of 54.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
5.99%
1-Month Change
10.19%
3-Month Change
8.60%
6-Month Change
1.72%
Year-to-Date (YTD) Change
1.72%
1-Year Change
50.88%
3-Year Change
122.42%
5-Year Change
177.98%
All-Time (Max) Change
8559.49%

Contact Information

31 10 703 8441
Willemstraat 5, Breda, NaN, 4811 AH

Company Facts

1,599 Employees
IPO DateApr 30, 2015
CountryNL
Actively Trading

Frequently Asked Questions